These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16338164)

  • 21. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploratory clinical trials: implementation modes & guidelines, scope and regulatory framework.
    Francillon A; Pickering G; Belorgey C
    Therapie; 2009; 64(3):149-59. PubMed ID: 19671427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative method of evaluating quality of international clinical studies in China: Analysis of site visit reports of the Clinical Research Operations and Monitoring Center.
    Chang JJ; Xu J; Fan D
    Contemp Clin Trials; 2008 Sep; 29(5):654-62. PubMed ID: 18450522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"].
    Hvidberg EF
    Ugeskr Laeger; 1994 Feb; 156(6):789-93. PubMed ID: 8016980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level.
    Berdaï D; Hotton JM; Lechat P;
    Therapie; 2010; 65(4):329-34. PubMed ID: 20854755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials.
    Falagas ME; Bliziotis IA
    Am J Med Sci; 2007 Sep; 334(3):171-9. PubMed ID: 17873530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is ICH exportable outside the European Union?
    Dent NJ
    Qual Assur; 2000; 8(1):19-31. PubMed ID: 11710304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of new Japanese GCP on pharmaceutical-company-directed clinical trials and physician-directed clinical studies in the surgical field].
    Nakajima T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):685-90. PubMed ID: 9571965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New recommendations for evaluating the effectiveness of treatment of solid tumors and principles of the Guidelines for Clinical Practice (GCP)].
    Gorbunova VA; Orel NF; Zaruk VA
    Vopr Onkol; 2001; 47(6):718-21. PubMed ID: 11826496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to establish GCP-units in Denmark?].
    Krogsgaard K; Andreasen PB
    Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(24):5551-2. PubMed ID: 14968802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Standards, guidelines and principles for clinical trials: medical products].
    Ziegler WJ; Perren SM
    Swiss Surg; 1995; (1):81-3. PubMed ID: 8581810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.